L & S Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-41,373
Closed -$4.29M 344
2024
Q3
$4.29M Buy
+41,373
New +$4.22M 0.45% 64
2023
Q2
Sell
-86,489
Closed -$6.5M 312
2023
Q1
$6.5M Buy
+86,489
New +$6.43M 0.91% 33
2020
Q3
Sell
-69,964
Closed -$5.13M 308
2020
Q2
$5.13M Buy
+69,964
New +$4.97M 0.76% 37
2019
Q4
Sell
-44,232
Closed -$3.25M 310
2019
Q3
$3.25M Buy
+44,232
New +$3.21M 0.45% 63
2017
Q3
Sell
-78,900
Closed -$5.85M 290
2017
Q2
$5.85M Buy
+78,900
New +$5.86M 1.03% 29
2016
Q3
Sell
-5,800
Closed -$425K 127
2016
Q2
$425K Hold
5,800
0.1% 79
2016
Q1
$410K Hold
5,800
0.1% 57
2015
Q4
$386K Hold
5,800
0.1% 71
2015
Q3
$368K Hold
5,800
0.11% 71
2015
Q2
$379K Buy
+5,800
New +$393K 0.1% 81

Other funds holding CL

L & S Advisors's CL Position: Q4 2024 in Review

L & S Advisors sold out of Colgate-Palmolive (CL) in Q4 2024, closing a stake of 41,373 shares — an estimated $4.29M sold.

L & S Advisors first reported a position in CL in Q2 2015 and held it in 10 quarters. The position peaked at $6.5M in Q1 2023. 1,932 funds tracked by Wall St. Rank hold CL as of Q4 2024.

  • L & S Advisors reported no remaining Colgate-Palmolive position as of Q4 2024 after selling out during the quarter.
  • L & S Advisors sold 41,373 Colgate-Palmolive shares in Q4 2024, an estimated $4.29M.
  • L & S Advisors first reported a position in Colgate-Palmolive in Q2 2015 and held it in 10 quarters.
  • L & S Advisors's Colgate-Palmolive position peaked at $6.5M in Q1 2023.
  • 1,932 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.

Based on L & S Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.